FDA Chief Hamburg Says Rx Ads Need Broader Disease Information
This article was originally published in The Pink Sheet Daily
Executive Summary
New commissioner notes FDA has limited authority in an overloaded media landscape as drug advertising again becomes a target on Capitol Hill.
You may also be interested in...
Industry Missing A Public Health Opening With DTC Ads, FDA’s Hamburg Says
The messages conveyed through pharmaceutical direct-to-consumer advertising, and FDA’s role in regulating such promotions, are ripe for re-examination, Commissioner Margaret Hamburg said July 25.
Industry Missing A Public Health Opening With DTC Ads, FDA’s Hamburg Says
The messages conveyed through pharmaceutical direct-to-consumer advertising, and FDA’s role in regulating such promotions, are ripe for re-examination, Commissioner Margaret Hamburg said July 25.
FDA Ad Enforcement Steams On; Are “Days Of Pushing The Envelope” Over?
FDA's aggressive enforcement of its advertising standards, and the agency's new enforcement allies, mean that industry may now have more to fear from a citation letter